7th CKD Drug Development Summit 2025
-
Location:
- Revere Hotel Boston Common
- 200 Stuart St
- Boston
- MA
- 02116
- United States
- View on a map
- More Information:
-
Contact:
- Organiser: Hanson Wade
- Name: Serena Lee
- Email: Serena.Lee@hansonwade.com
Welcome to the Definitive Industry Focused Forum for Innovating Renal Drug Development
Advance More Personalized Therapies for Rare & Common Kidney Diseases
The transformative era of kidney drug development is here, with 2024 bringing landmark advancements, including Novartis’ Borealis Biosciences and approvals in IgAN, Travere Therapeutics, and industry-defining acquisitions by Biogen and Vertex. Breakthrough therapies like SGLT2 inhibitors, GLP-1s, and MRAs continue to reshape the CKD treatment paradigm, while the FDA’s accelerated pathways fuel unprecedented innovation. We are witnessing a renaissance in chronic kidney disease research and development and treatment.
The 7th CKD Drug Development Summit returns in 2025 as the definitive forum for connecting industry leaders, KOLs, researchers, and regulators. Addressing the most pressing challenges across renal research and development, this event serves as the unrivaled platform to share breakthroughs, inspire collaboration, and advance strategies for improving clinical outcomes in renal care all to bring better drugs to patients faster.
